Caresyntax Funding Rounds: Investors, Investments, and Exits

Investors

Caresyntax has raised a total of $173.3 million in funding over 7 rounds. The most recent funding round was a Series D round led by Optum Ventures and surgical.aI in October of 2021, raising $40 million.

• Optum Ventures
• surgical.ai
• OrbiMed Advisors
• FCG
• Avista Capital Partners
• Earlybird Health
• Wellington Management Company LLP

Investments

Caresyntax's funding has been used to invest in the following areas:

• Product development
• Sales and marketing
• Global expansion
li>Strategic acquisitions

Exits

Caresyntax has not had any exits to date.

Conclusion

Caresyntax is a rapidly growing company with a strong track record of innovation and success. The company's funding rounds have helped it to invest in new products and services, expand globally, and make strategic acquisitions. Caresyntax is well-positioned to continue its growth and success in the years to come.